Les atouts des modèles cellulaires

www.cerep.com/ Guguen-Guillouzo, 1983, Exp Cell Res, 143, 47, 10.1016/0014-4827(83)90107-6 Fautrel, 1997, Toxicol AppI Pharmacol, 147, 110, 10.1006/taap.1997.8253 Guyomard, 1996, Toxicol AppI Pharmacol, 141, 349, 10.1006/taap.1996.0299 Rodrigues, 1994, Biochem Pharmacol, 48, 2147, 10.1016/0006-2952(94)00312-2 Guillouzo, 1995, Hépatotoxicité in vitro, 69 Guillouzo, 1998, Env Health Perspect Integration of in vitro approaches to predict drug metabolism ana interactions in man in development of pharmaceuticals, BIOMED2, BMH4960254, 1er min 1996-31 mai 1999. Establishment of stable immortal differentiated cell lines for the development of in vitro tests new cell lines for in vitro tests, BIOTECH2, BI04960052,1er décembre 1996-30 novembre 1999 Fautrel, 1993, ATLA (Alternatives to laboratory animals), 21, 281, 10.1177/026119299302100223 Toxicology in vitro, n∘ spécial, sous presse 1998.